DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

RP59500 (Quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium.

Author(s): Cassell J, Balakrishnan I, Samarasinghe D, Mistry P, Prentice HG, Gillespie SH

Affiliation(s): Department of Medical Microbiology, Royal Free Hospital School of Medicine, London, UK.

Publication date & source: 1998-05, J Infect., 36(3):324-7.

Publication type: Case Reports

We describe three cases of Enterococcus faecium sepsis arising in immunocompromised patients, severely ill with other conditions, who were treated with the new injectable streptogramin RP59500. There are still few reports of clinical experience with this drug. All had bacteriological resolution, with one patient recovering fully. Although two of the three patients died, this was due to underlying disease in one case and a gram-negative superinfection in another. Quinupristin/dalfopristin therapy was not associated with significant adverse effects in any of the patients.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017